Coya Therapeutics (COYA) Cash from Investing Activities (2022 - 2026)

Coya Therapeutics has reported Cash from Investing Activities for 5 years, with the latest figure at -$885000.0 in Q1 2026.

• Quarterly Cash from Investing Activities changed N/A year-over-year to -$885000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (changed N/A YoY) and the FY2025 annual result came in at -$1.2 million, down 4558.41% from the prior year.
• Cash from Investing Activities declined to -$885000.0 in Q1 2026 per COYA's latest filing, from -$648606.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$25000.0 in Q1 2024 and troughed at -$885000.0 in Q1 2026.
• A 5-year average of -$428358.4 and a median of -$390000.0 in 2022 frame the typical range for Cash from Investing Activities.
• The widest YoY moves for Cash from Investing Activities: up 50.47% in 2023, down 50.47% in 2023.
• Over 5 years, Cash from Investing Activities stood at -$390000.0 in 2022, then jumped by 50.47% to -$193186.0 in 2023, then jumped by 87.06% to -$25000.0 in 2024, then slumped by 2494.42% to -$648606.0 in 2025, then plunged by 36.45% to -$885000.0 in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$885000.0, -$648606.0, and -$25000.0 for Q1 2026, Q4 2025, and Q1 2024 respectively.